000 | 01749 a2200529 4500 | ||
---|---|---|---|
005 | 20250513202036.0 | ||
264 | 0 | _c20000301 | |
008 | 200003s 0 0 eng d | ||
022 | _a0006-291X | ||
024 | 7 |
_a10.1006/bbrc.1999.2018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKruger, E A | |
245 | 0 | 0 |
_aEndostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _cFeb 2000 |
||
300 |
_a183-91 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD34 _xmetabolism |
650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
650 | 0 | 4 |
_aCollagen _xgenetics |
650 | 0 | 4 | _aEndostatins |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicroscopy, Electron |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPeptide Fragments _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
650 | 0 | 4 |
_aSaphenous Vein _xdrug effects |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aDuray, P H | |
700 | 1 | _aTsokos, M G | |
700 | 1 | _aVenzon, D J | |
700 | 1 | _aLibutti, S K | |
700 | 1 | _aDixon, S C | |
700 | 1 | _aRudek, M A | |
700 | 1 | _aPluda, J | |
700 | 1 | _aAllegra, C | |
700 | 1 | _aFigg, W D | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 268 _gno. 1 _gp. 183-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.1999.2018 _zAvailable from publisher's website |
999 |
_c10607268 _d10607268 |